In ALK+ ALCL cell lines, treatment with anti-CD95 had no effect on cell viability and did not enhance cell death induction by crosslinked anti-CD74 antibody (Figure 3C, left panel). Here, CD74 is linked to anaplastic large cell lymphoma.